NTLA

Q: What is the price of Intellia Therapeutics (NTLA) today?

The price of Intellia Therapeutics (NTLA) today is R$ 61,57, with a variation of -51.82% compared to the last year. The price of Intellia Therapeutics (NTLA) started the year trading around R$ 63,20 and today it is at R$ 61,57. Follow the real-time price chart, the historical price of Intellia Therapeutics (NTLA), and stock data from Ibovespa and international markets.

Q: When does Intellia Therapeutics (NTLA) pay dividends?

Intellia Therapeutics (NTLA) did not distribute dividends in the last year.

Q: Intellia Therapeutics (NTLA) is it worth it?

Currently, Intellia Therapeutics (NTLA) is priced at R$ 61,57, with a P/E of -2,28%, representing a deviation of -9,89% from its historical average P/E. In the last year, the stock showed a variation of -51.82% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -51,82%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of Intellia Therapeutics (NTLA)?

Investing in shares of Intellia Therapeutics (NTLA) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of Intellia Therapeutics (NTLA) yield today?

The yield of Intellia Therapeutics (NTLA) was -16,44% in the last month, -51,82% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of Intellia Therapeutics (NTLA) today, the total investment would be based on the current price of R$ 61,57.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 2.966,50In 5 years: R$ 6.157,12In 10 years: 6.157,12It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Intellia Therapeutics Inc.

Price

US$ 11,36

variation (12m)

-51,82%

p/l

-2,28

p/vp

1,53

DIVIDEND YIELD

0,00%

quote NTLA

BVMF

NTLA

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of NTLA

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-16,44%

3 months

17,60%

1 year

-51,82%

2 years

-70,30%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

-16,44%

3 months

17,01%

1 year

-54,22%

2 years

-72,93%

5 years

0,00%

10 years

0,00%

Indicators NTLA

check out the fundamentals of Intellia Therapeutics shares

P/L

-2,28

Sector: -3,27 Industry: -3,27

P/SALES (PSR)

20,70

Sector: -3,77 Industry: -3,77

P/VP

1,53

Sector: 1,74 Industry: 1,74

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-53,42%

Sector: -63,50% Industry: -63,50%

ROE

-67,14%

Sector: -67,23% Industry: -67,23%

ROIC

-91,33%

Sector: -2.087,74% Industry: -2.087,74%

Net Margin

-100,00%

Sector: -43,34% Industry: -43,34%

GROSS MARGIN

100,00%

Sector: 40,50% Industry: 40,50%

OPERATING MARGIN

-100,00%

Sector: -43,21% Industry: -43,21%

P/EBITDA

-2,18

Sector: -3,13 Industry: -3,13

P/EBIT

-2,14

Sector: -3,41 Industry: -3,41

P/ASSETS

1,22

Sector: 1,29 Industry: 1,29

VPA

6,88

Sector: 1,80 Industry: 1,80

LPA

-4,62

Sector: -2,09 Industry: -2,09

EQUITY / ASSETS

0,80

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

-1,84%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

29,04%

Sector: - Industry: -

NTLA indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
JNJ	19,04	5,50	28,88%	2,80%	US$ 431,37 B	25,00%
PFE	13,45	1,62	12,08%	6,68%	US$ 144,63 B	16,84%
ABBV	79,66	228,58	286,94%	3,38%	US$ 334,19 B	7,31%
NVO	15,51	9,75	62,86%	2,83%	US$ 253,39 B	35,63%
MRK	13,05	4,36	33,44%	3,75%	US$ 214,13 B	25,79%
BMY	19,31	5,58	28,87%	5,13%	US$ 97,52 B	10,58%
GILD	22,64	7,29	32,21%	2,72%	US$ 142,89 B	21,87%
AZN	30,26	5,60	18,51%	1,91%	US$ 251,01 B	14,68%
ZTS	26,68	14,00	52,48%	1,19%	US$ 69,70 B	27,83%
HALO	15,59	26,12	167,47%	0,00%	US$ 8,69 B	47,28%
REGN	13,88	2,07	14,89%	0,30%	US$ 61,90 B	31,37%
AMGN	23,87	21,27	89,11%	3,15%	US$ 158,02 B	18,96%
VRTX	27,92	5,91	21,18%	0,00%	US$ 101,55 B	31,86%
ADMA	20,53	10,77	52,45%	0,00%	US$ 4,29 B	44,06%
MCK	27,24	-99,86	-366,63%	0,41%	US$ 86,18 B	0,84%
BIIB	13,38	1,16	8,68%	0,00%	US$ 20,48 B	15,31%
CAH	22,58	-13,38	-59,26%	1,37%	US$ 35,25 B	0,70%

comparison of NTLA with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history NTLA dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Intellia Therapeutics

Intellia Therapeutics Inc.

Average user rating I10

4.0 (3 people)

Estados Unidos

11 years

Foundation: 2014

2016

Year of debut on the stock exchange - 9 years

312

Employees

The Company Intellia Therapeutics Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 1,09 Billion, having a net worth of $ 715,25 Milhões.

With a total of 312 employees, the company is listed in the sector of Cuidados de saúde and categorized in industry of Biotecnologia.

In the last 12 months the Company had a revenue of $ 52,85 Milhões, which generated a loss in the amount of $ -480,19 Milhões.

As for its main indicators, the Company has a P/E ratio of -2,28, a P/B ratio of 1,53 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker NTLA.

Market value

US$ 1,09 Billion

Net worth

US$ 715,25 Milhões

US$ 715.250.000,00

Assets

US$ 898,89 Milhões

US$ 898.890.000,00

Total Number of Shares

104,00 Milhões

104.000.000

Average Daily Trading Volume

US$ 4,72 Milhões

US$ 4.719.194,92

Sector

Cuidados de saúde

Industry

Biotecnologia

NTLA

NTLA revenue and profits

NTLA results

DRAG THE FRAME TO SEE MORE DATA

NTLA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 680,52 24,27% (12 M)

P/L

27,24

0,41%

ROE

-366,63%

P/VP

-99,86

CAH - Cardinal Health

US$ 147,49 36,56% (12 M)

P/L

22,58

1,37%

ROE

-59,26%

P/VP

-13,38

JNJ - Johnson & Johnson

US$ 176,49 12,66% (12 M)

P/L

19,04

2,80%

ROE

28,88%

P/VP

5,50

MRK - Merck & Co.

US$ 84,99 --23,85% (12 M)

P/L

13,05

3,75%

ROE

33,44%

P/VP

4,36

PFE - Pfizer

US$ 24,92 --5,92% (12 M)

P/L

13,45

6,68%

ROE

12,08%

P/VP

1,62

AZN - AstraZeneca

US$ 80,05 --5,68% (12 M)

P/L

30,26

1,91%

ROE

18,51%

P/VP

5,60

ABBV - AbbVie

US$ 208,36 10,15% (12 M)

P/L

79,66

3,38%

ROE

286,94%

P/VP

228,58

Common Questions

What is the price of Intellia Therapeutics (NTLA) today?

The price of Intellia Therapeutics (NTLA) today is R$ 61,57, with a variation of -51.82% compared to the last year. The price of Intellia Therapeutics (NTLA) started the year trading around R$ 63,20 and today it is at R$ 61,57. Follow the real-time price chart, the historical price of Intellia Therapeutics (NTLA), and stock data from Ibovespa and international markets.

When does Intellia Therapeutics (NTLA) pay dividends?

Intellia Therapeutics (NTLA) did not distribute dividends in the last year.

Intellia Therapeutics (NTLA) is it worth it?

Currently, Intellia Therapeutics (NTLA) is priced at R$ 61,57, with a P/E of -2,28%, representing a deviation of -9,89% from its historical average P/E. In the last year, the stock showed a variation of -51.82% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -51,82%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of Intellia Therapeutics (NTLA)?

Investing in shares of Intellia Therapeutics (NTLA) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of Intellia Therapeutics (NTLA) yield today?

The yield of Intellia Therapeutics (NTLA) was -16,44% in the last month, -51,82% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of Intellia Therapeutics (NTLA) today, the total investment would be based on the current price of R$ 61,57.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 2.966,50
In 5 years: R$ 6.157,12
In 10 years: 6.157,12

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

NTLA

Intellia Therapeutics Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of NTLA

check out the fundamentals of Intellia Therapeutics shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Intellia Therapeutics

Intellia Therapeutics Inc.

Estados Unidos

11 years

2016

312

PROFIT X PRICE NTLA

NTLA results

NTLA cash flow

evolution of assets - NTLA

NTLA balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

PFE - Pfizer

AZN - AstraZeneca

ABBV - AbbVie

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80